'Molecular commando' identified to tackle hypoxia pathway

November 7, 2016 by Roddy Isles, University of Dundee
`Molecular commando’ identified to tackle hypoxia pathway
Credit: University of Dundee

Scientists at the University of Dundee have identified a 'molecular commando' which can be stealthily deployed to activate a hypoxic response, a process which can help to fight a range of conditions including stroke, angina, colitis and brain injuries.

A Dundee team led by Professor Alessio Ciulli in the School of Life Sciences have used pioneering techniques to develop a 'small molecule' chemical probe called VH298, which offers highly targeted access to the parts of the cell which regulate hypoxia, known as the hypoxic signalling pathway.

"Using a small molecule like this offers a highly targeted option to control the hypoxic pathway, and one which can sneak in under the cell's natural defences to perform its work, a bit like a molecular commando," said Professor Ciulli.

The research has been published in Nature Communications.

Active hypoxic signalling can be both good and bad, depending on context. In diseases like cancer it can be a bad thing as it can help tumour cells to survive and prosper. However, a hypoxic response can provide therapeutic benefits in conditions such as ischaemic injuries to the brain or heart, including stroke, and anaemia due to or chemotherapy.

Being able to control the hypoxic signalling pathway offers the prospect of finding new drugs which could be deployed in those cases. Existing methods include genetic knockouts which affect the entire pathway and chemical tools which interfere with multiple processes, and until now it had been hard to be more selective in picking a single target.

"The difficulty with some of the existing methods of tackling this pathway are that they affect stages which are also involved in other processes, meaning you are potentially triggering side effects, which makes it harder to control the overall outcomes," said Professor Ciulli.

"We have identified a stage of the pathway that is very specific and doesn't have this broad range of activity. By targeting it we can be much more specific in the actions we are triggering in the cell.

"This is important as a because it means we can make better measurements of cause and effect and build more information about how hypoxia works and how we may be able to control it. It also offers a potentially drug target in itself.

"The difference in approach between for example gene knockouts and our small molecule method is a bit like between blowing up the whole factory or sneaking someone in to take out the little bit that you want to."

The use of like this is a growing area of drug development, offering the prospect of highly specific treatments for many conditions. Successfully identifying and developing suitable small molecules, however, is extremely complex.

"We have been able to develop this project due to the world-class expertise we have at Dundee, bringing together people from different laboratories and areas of knowledge," said Professor Ciulli. "So in my lab we work on design and studying how this types of molecules work but we are also able to call on scientists like Sonia Rocha, with expertise in oxygen sensing pathways, Doreen Cantrell, whose world-renowned work includes the role of hypoxia in immune cells, and Kevin Read in our Drug Discovery Unit, who has helped us maximise the drug-like properties of the molecule.

"It is this combination of world-class work that has helped make Dundee the top-ranked place in the UK for biological sciences research. Our new molecule will be made available to the wide scientific community for use as inhibitor in biological research."

Explore further: A novel noninvasive imaging probe for fast and sensitive detection of cancer

More information: Julianty Frost et al. Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition, Nature Communications (2016). DOI: 10.1038/ncomms13312

Related Stories

Cutting off the oxygen supply to serious diseases

January 30, 2012

A new family of proteins which regulate the human body's 'hypoxic response' to low levels of oxygen has been discovered by scientists at Barts Cancer Institute at Queen Mary, University of London and The University of Nottingham.

Stiff and oxygen-deprived tumors promote spread of cancer

September 13, 2016

When Hippocrates first described cancer around 400 B.C., he referred to the disease's telltale tumors as "karkinos"—the Greek word for crab. The "Father of Western Medicine" likely noted that cancer's creeping projections ...

Scientists find new path in brain to ease depression

October 5, 2016

Northwestern Medicine scientists have discovered a new pathway in the brain that can be manipulated to alleviate depression. The pathway offers a promising new target for developing a drug that could be effective in individuals ...

Recommended for you

Archaeologists discover Incan tomb in Peru

February 16, 2019

Peruvian archaeologists discovered an Incan tomb in the north of the country where an elite member of the pre-Columbian empire was buried, one of the investigators announced Friday.

Where is the universe hiding its missing mass?

February 15, 2019

Astronomers have spent decades looking for something that sounds like it would be hard to miss: about a third of the "normal" matter in the Universe. New results from NASA's Chandra X-ray Observatory may have helped them ...

What rising seas mean for local economies

February 15, 2019

Impacts from climate change are not always easy to see. But for many local businesses in coastal communities across the United States, the evidence is right outside their doors—or in their parking lots.

The friendly extortioner takes it all

February 15, 2019

Cooperating with other people makes many things easier. However, competition is also a characteristic aspect of our society. In their struggle for contracts and positions, people have to be more successful than their competitors ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.